Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Reprod Sci ; 31(5): 1204-1214, 2024 May.
Article in English | MEDLINE | ID: mdl-38151656

ABSTRACT

Extracellular vehicles (EVs) have been involved in several aspects of pregnancy, including endometrial receptivity, embryo implantation, and embryo-maternal communication showing them associated with pregnancy disorders, such as preeclampsia, gestational diabetes mellitus, and preterm birth. Further research is warranted to fully comprehend the exact pathophysiological roles of EVs and to develop new therapies targeting EVs thereby improving pregnancy outcomes. Herein, we review the recent knowledge on the multifaceted roles of EVs during pregnancy and address the majority of the molecular interactions between EVs, maternal, and fetal cells with an emphasis on disorders of pregnancy under the influence of EVs. Moreover, we also discuss its applications in clinical trials followed by prospects.


Subject(s)
Extracellular Vesicles , Humans , Pregnancy , Extracellular Vesicles/metabolism , Female , Animals , Pregnancy Complications/metabolism , Pregnancy Complications/therapy , Embryo Implantation/physiology
2.
J Pediatr Endocrinol Metab ; 35(11): 1429-1432, 2022 Nov 25.
Article in English | MEDLINE | ID: mdl-36106528

ABSTRACT

OBJECTIVES: Rabson Mendenhall syndrome  (RMS) is a rare form of insulin resistance syndrome caused by insulin receptor mutation. In term of severity, it lies at an intermediate point on spectrum of insulin resistance with Donohue syndrome flanking the severe and Type A insulin resistance at the mild end. We are reporting a 3.5-month-old boy with RMS along with its management challenges in a resource limited country. CASE PRESENTATION: An infant presented at 3.5-month of an age with failure to thrive and fluctuating blood glucose level (hyperglycaemia and hypoglycaemia) along with clinical features of insulin resistance. He was found to have raised HbA1C, high insulin and C peptide level and a homozygous mutation in INSR gene c.1049C>T, (p.Ser350 Leu) confirming the diagnosis of RMS. He was managed with long-acting insulin (Detemir) along with frequent feeding. CONCLUSIONS: RMS in resource limited countries could be managed with frequent feeding along with insulin. Early diagnosis and management can improve long term outcome.


Subject(s)
Donohue Syndrome , Insulin Resistance , Infant , Male , Humans , Donohue Syndrome/genetics , Insulin Resistance/genetics , Receptor, Insulin/genetics , Insulin/genetics , Mutation
SELECTION OF CITATIONS
SEARCH DETAIL
...